Path Integration Detects Prodromal Alzheimer’s Disease and Predicts Cognitive Decline
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-240347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Haruo Hanyu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Center, Tokyo General Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Magnetic Resonance Imaging, Prodromal Symptoms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
The entorhinal cortex is the very earliest involvement of Alzheimer’s disease (AD). Grid cells in the medial entorhinal cortex form part of the spatial navigation system.
Objective
We aimed to determine whether path integration performance can be used to detect patients with mild cognitive impairment (MCI) at high risk of developing AD, and whether it can predict cognitive decline.
Methods
Path integration performance was assessed in 71 patients with early MCI (EMCI) and late MCI (LMCI) using a recently developed 3D virtual reality navigation task. Patients with LMCI were further divided into those displaying characteristic brain imaging features of AD, including medial temporal lobe atrophy on magnetic resonance imaging and posterior hypoperfusion on single-photon emission tomography (LMCI+), and those not displaying such features (LMCI–).
Results
Path integration performance was significantly lower in patients with LMCI+than in those with EMCI and LMCI–. A significantly lower performance was observed in patients who showed progression of MCI during 12 months, than in those with stable MCI. Path integration performance distinguished patients with progressive MCI from those with stable MCI, with a high classification accuracy (a sensitivity of 0.88 and a specificity of 0.70).
Conclusions
Our results suggest that the 3D virtual reality navigation task detects prodromal AD patients and predicts cognitive decline after 12 months. Our navigation task, which is simple, short (12–15 minutes), noninvasive, and inexpensive, may be a screening tool for therapeutic choice of disease-modifiers in individuals with prodromal AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dementia Research Center, Tokyo General Hospital, Tokyo, Japan.
- Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.
- Department of Rehabilitation, Tokyo General Hospital, Tokyo, Japan.
- Department of Neurosurgery, Tokyo General Hospital, Tokyo, Japan.
- Department of Biofunctional Imaging, Fukushima Medical University, Fukushima, Japan.
- Laboratory for Alzheimer's Disease, Department of Life Science, Faculty of Science, Gakushuin University, Tokyo, Japan.
Zitieren
APA
Hanyu, H., Koyama, Y., Umekida, K., Watanabe, S., Matsuda, H., Koike, R., & Takashima, A. (2024). Path Integration Detects Prodromal Alzheimer’s Disease and Predicts Cognitive Decline. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240347
Vancouver
Hanyu H, Koyama Y, Umekida K, Watanabe S, Matsuda H, Koike R, et al. Path Integration Detects Prodromal Alzheimer’s Disease and Predicts Cognitive Decline. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240347
BibTeX
@article{Hanyu2024,
author = {Hanyu, Haruo and Koyama, Yumi and Umekida, Kazuki and Watanabe, Sadayoshi and Matsuda, Hiroshi and Koike, Riki and Takashima, Akihiko},
title = {Path Integration Detects Prodromal Alzheimer’s Disease and Predicts Cognitive Decline},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-240347}
}
EUVIMED